Tech Company Financing Transactions
Archemix Funding Round
Archemix, based in Cambridge, secured $50 million from Highland Capital Partners, Atlas Venture and MDS Capital.
Transaction Overview
Company Name
Announced On
4/14/2004
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
Highland Capital Partners (Lead Investor) (Corey Mulloy)
Proceeds Purpose
The funding will be used for the continued clinical development of Archemix's substantial portfolio of aptamer therapeutics.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
148 Sidney St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
The company is leading the development of aptamers as a new class of directed therapeutics for the prevention and treatment of chronic and acute diseases. With their unique properties, aptamers offer an alternative to biologics and small molecules in numerous applications and hold extraordinary potential to address unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ken Bate
VP - Bus. Development
John Harre
VP - R & D
Robert Schaub
Browse more venture capital transactions:
Prev: 4/13/2004: Hospital Partners of America venture capital transaction
Next: 4/15/2004: Visto venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs